Treatment of chronic urticaria in children with antihistamines and cyclosporine

Journal of Allergy and Clinical Immunology: In Practice

Volumn 2, Issue 4, 2014, Pages 434-438

  Neverman, Lisa ^a   Weinberger, Miles ^a  

^a UNIVERSITY OF IOWA CHILDREN S HOSPITAL   (United States)

Author keywords

Antihistamines; Autoantibodies; Cetirizine; Cyclosporine; Hives; Hydroxyzine; Immunoglobulin E; Urticaria

Indexed keywords

ANTIHISTAMINIC AGENT; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CETIRIZINE; CYCLOSPORIN A; DOXEPIN; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYZINE; OMALIZUMAB; PREDNISONE; SALAZOSULFAPYRIDINE; CYCLOSPORIN;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; ARTICLE; CHILD; CHRONIC URTICARIA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; MALE; RELAPSE; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT OUTCOME; TREATMENT RESPONSE; BLOOD; CHRONIC DISEASE; DRUG RESISTANCE; RECURRENT DISEASE; UNITED STATES; URTICARIA;

ADOLESCENT; AUTOANTIBODIES; CHILD; CHRONIC DISEASE; CYCLOSPORINE; DRUG RESISTANCE; FEMALE; HISTAMINE ANTAGONISTS; HUMANS; IOWA; MALE; RECURRENCE; TREATMENT OUTCOME; URTICARIA;

EID: 84904056579     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2014.04.011     Document Type: Article

References (33)

1. Sabroe R.A. Acute urticaria. Immunol Allergy Clin North Am 2014, 34:11-21.
2. Kaplan A.P. What the first 10,000 patients with chronic urticaria have taught me: a personal journey. JAllergy Clin Immunol 2009, 123:713-717.
3. Morgan M., Khan D.A. Therapeutic alternatives for chronic urticaria: an evidence-based review, part 1. Ann Allergy Asthma Immunol 2008, 100:403-412.
4. Fradin M.S., Ellis C.N., Goldfarb M.T., Voorhees J.J. Oral cyclosporine for severe chronic idiopathic urticaria and angioedema. JAm Acad Dermatol 1991, 25:1065-1067.
5. Toubi E., Blant A., Kessel A., Golan T.D. Low-dose cyclosporin A in the treatment of severe chronic idiopathic urticaria. Allergy 1997, 52:312-316.
6. Loria M.P., Dambra P.P., D'Oronzio L., Nettis E., Pannofino A., Cavallo E., et al. Cyclosporin A in patients affected by chronic idiopathic urticaria: a therapeutic alternative. Immunopharmacol Immunotoxicol 2001, 23:205-213.
7. Di Gioacchino M., Di Stefano F., Cavallucci E., Verna N., Ramondo S., Paolini F., et al. Treatment of chronic idiopathic urticaria and positive autologous serum skin test with cyclosporine: clinical and immunological evaluation. Allergy Asthma Proc 2003, 24:285-290.
8. Grattan C.E., O'Donnell B.F., Francis D.M., Niimi N., Barlow R.J., Seed P.T., et al. Randomized double-blind study of cyclosporine in chronic 'idiopathic' urticaria. Br J Dermatol 2000, 143:365-372.
9. Doshi D.R., Weinberger M.M. Experience with cyclosporine in children with chronic idiopathic urticaria. Pediatr Dermatol 2009, 26:409-413.
10. Gengo F.M., Dabronzo J., Yurchak A., Love S., Miller J.K. The relative antihistaminic and psychomotor effects of hydroxyzine and cetirizine. Clin Pharmacol Ther 1987, 42:265-272.
11. Bizikova P., Papich M.G., Olivry T. Hydroxyzine and cetirizine pharmacokinetics and pharmacodynamics after oral and intravenous administration of hydroxyzine to healthy dogs. Vet Dermatol 2008, 19:348-357.
12. Cook T.J., MacQueen D.M., Wittig H.J., Thornby J.I., Lantos R.L., Virtue C.M. Degree and duration of skin test suppression and side effects with antihistamines: a double blind controlled study with five antihistamines. JAllergy Clin Immunol 1973, 51:71-77.
13. Rhoades R.B., Leifer K.N., Cohan R., Wittig H.J. Suppression of histamine-induced pruritus by three antihistaminic drugs. JAllergy Clin Immunol 1975, 55:180-185.
14. Dos Santos R.V., Magerl M., Mlynek A., Lima H.C. Suppression of histamine- and allergen-induced skin reactions: comparison of first- and second generation antihistamines. Ann Allergy Asthma Immunol 2009, 102:495-499.
15. Elder C.A., Moore M., Chang C.T., Jin J., Charnick S., Nedelman J., et al. Efficacy and pharmacokinetics of two formulations of cyclosporine A in patients with psoriasis. JClin Pharmacol 1995, 35:865-875.
16. Biagtan M.J., Viswanathan R.K., Evans M.D., Mathur S.K. Clinical utility of the chronic urticaria index. JAllergy Clin Immunol 2011, 127:1626-1627.
17. Cho C.B., Stutes S.A., Altrich M.L., Ardoin S.P., Phillips G., Ogbogu P.U. Autoantibodies in chronic idiopathic urticaria and nonurticarial systemic autoimmune disorders. Ann Allergy Asthma Immunol 2013, 110:29-33.
18. Sabroe R.A., Fiebiger E., Francis D.M., Maurer D., Seed P.T., Grattan C.E., et al. Classification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity. JAllergy Clin Immunol 2002, 110:492-499.
19. Kaplan A.P., Joseph K. Basophil secretion in chronic urticarial: autoantibody-dependent or not. JAllergy Clin Immunol 2007, 120:729-730.
20. Fedorowicz Z., van Zuuren E.J., Hu N. Histamine H2-receptor antagonists for urticaria. Cochrane Database Syst Rev 2012, 3:CD008596.
21. Bensch G., Borish L. Leukotriene modifiers in chronic urticaria. Ann Allergy Asthma Immunol 1999, 83:348.
22. Tedeschi A., Suli C., Lorini M., Airaghi L. Successful treatment of chronic urticaria. Allergy 2000, 55:1097-1098.
23. Bagenstose S.E., Levin L., Bernstein J.A. The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results. JAllergy Clin Immunol 2004, 113:134-140.
24. Erbagci Z. The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study. JAllergy Clin Immunol 2002, 110:484-488.
25. Godse K.V. Oral montelukast monotherapy is ineffective in chronic idiopathic urticaria: a comparison with oral cetirizine. Indian J Dermatol Venereol Leprol 2006, 72:312-314.
26. Reimers A., Pichler C., Helbling A., Pichler W.J., Yawalkar N. Zafirlukast has no beneficial effects in the treatment of chronic urticaria. Clin Exp Allergy 2002, 32:1763-1768.
27. Di Lorenzo G., D'Alcamo A., Rizzo M., Leto-Barone M.S., Bianco C.L., Ditta V., et al. Leukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: a systematic review. JAsthma Allergy 2008, 2:9-16.
28. Goldsobel A.B., Rohr A.S., Siegel S.C., Spector S.L., Katz R.M., Rachelefsky G.S., et al. Efficacy of doxepin in the treatment of chronic idiopathic urticaria. JAllergy Clin Immunol 1986, 78:867-873.
29. Orden R.A., Timble H., Saini S.S. Efficacy and safety of sulfasalazine in patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2014, 112:64-70.
30. Khan D.A. Alternative agents in refractory chronic urticaria: evidence and considerations on their selection and use. JAllergy Clin Immunol Pract 2013, 1:433-440.
31. Maurer M., Rosén K., Hsieh H.J., Saini S., Grattan C., Gimenéz-Arnau A., et al. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. NEngl J Med 2013, 368:924-935.
32. Staevska M., Topov T.A., Kralimarkova T., Lasarova C., Kraeva S., Popova D., et al. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria. JAllergy Clin Immunol 2010, 125:676-682.
33. Breneman D.L. Cetirizine versus hydroxyzine and placebo in chronic idiopathic urticaria. Ann Pharmacother 1996, 30:1075-1079.